Table 2.
Analysis of vitals and clinical data between groups.
| Nicardipine (n = 40) | Esmolol (n = 42) | p | |
|---|---|---|---|
| Mean ± sd/median (25–75) | Mean ± sd/median (25–75) | ||
| Systolic BP (mmHg) | 188 (182–199) | 190 (185–200) | 0.321m |
| Diastolic BP (mmHg) | 109 (100–110) | 105 (100–115) | 0.765m |
| End systolic BP | 157.0 ± 9.8 | 170.6 ± 6.7 | < 0.001 † |
| End diastolic BP | 83.7 ± 5.2 | 91.5 ± 5.3 | < 0.001 † |
| BP control time (min) | 19.0 ± 6.35 | 25.4 ± 8.7 | < 0.001 † |
| Pulse | 80 (76–90) | 87 (80–97) | 0.047 m |
| Tempereture ( C) | 36.7 (36.7–36.9) | 36.8 (36.7–36.9) | 0.418m |
| Breathing (/min) | 14 (13–16) | 15 (14–18) | 0.157m |
| Saturation | 98 (96–99) | 96 (96–99) | 0.256m |
| NIHSS at admission | 10.5 ± 5.9 | 12.8 ± 7.5 | 0.131† |
| Symptom door duration (min) | 63.1 ± 37.1 | 79.2 ± 42.0 | 0.070† |
| Symptom needle Dur. (min) | 160.5 ± 58.1 | 174.8 ± 48.2 | 0.228† |
| Door needle duration (min) | 97.4 ± 56.2 | 95.6 ± 41.04 | 0.866† |
| Hospitalisation (day) | 11 (7–21) | 10 (7–16) | 0.375m |
| mRS | 3 (1–6) | 3 (1–6) | 0.691m |
| ICH (+) n(%) | 14 (35%) | 12 (28.6%) | 0.698 χ2 |
| Mortality (+) n(%) | 13 (32.5%) | 12 (28.6%) | 0.699 χ2 |
Significant values are given in bold.
BP blood pressure, mRS modified Rankin scale, ICH intracerebral haemorrhage, Dur duration, Min minute.
†Independent T test.
mMann Whitney U.
χ2Chi-square test.